ConductScience.org, home

Gene · 3451

IFNA17: interferon alpha 17

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. IFNA17: interferon alpha 17. Genes, record 3451. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3451

On this page

Gene

Symbol
IFNA17
HGNC
Name
interferon alpha 17
HGNC
NCBI Gene ID
3451
NCBI Gene
HGNC ID
HGNC:5422
HGNC
Ensembl
ENSG00000234829
NCBI Gene
Aliases
IFN-alphaI, IFNA, INFA, LEIF2C1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P01571Interferon alpha-171890Ensembl, GeneID, HGNC

Source UniProt

Patents84

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4705273 A22026-03-11540P01571Espacenet
EP 4650780 A22025-11-1913736P01571Espacenet
JP 2025169942 A2025-11-141095P01571Espacenet
JP 2025147176 A2025-10-066731P01571Espacenet
JP 2025529142 A2025-09-046650P01571Espacenet
US 12371689 B22025-07-296650P01571Espacenet
JP 2025517970 A2025-06-1213736P01571Espacenet
JP 2025028160 A2025-02-286731P01571Espacenet
JP 2025013347 A2025-01-24540P01571Espacenet
JP 2025502205 A2025-01-249812P01571Espacenet

1 to 10 of 84

See all 84 patents

Drugs2

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
RONTALIZUMABCHEMBL1743066Interferon alpha inhibitorINHIBITORChEMBL
SIFALIMUMABCHEMBL1743069Interferon alpha inhibitorINHIBITORChEMBL

Trials10

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT01283139SIFALIMUMABPHASE22016-07-11ClinicalTrials.gov
NCT01031836SIFALIMUMABPHASE22018-11-19ClinicalTrials.gov
NCT00979654SIFALIMUMABPHASE22016-08-23ClinicalTrials.gov
NCT00962832RONTALIZUMABPHASE2ClinicalTrials.gov
NCT00657189SIFALIMUMABPHASE2ClinicalTrials.gov
NCT00541749RONTALIZUMABPHASE1ClinicalTrials.gov
NCT00533091SIFALIMUMABPHASE1ClinicalTrials.gov
NCT00482989SIFALIMUMABPHASE1ClinicalTrials.gov
NCT00472758SIFALIMUMABPHASE1ClinicalTrials.gov
NCT00299819SIFALIMUMABPHASE1ClinicalTrials.gov

NIH grants1,175

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleIFNA17 papersNewest fiscal year
P30CA016672Cancer Center Support Grant142025
P30CA008748Cancer Center Support Grant122025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success42025
P30AI050409Center for AIDS Research at Emory University32025
P30CA006927Comprehensive Cancer Center Program at Fox Chase32025
P30CA016056Roswell Park Cancer Center Support Grant32025
P30DK097512Indiana Diabetes Research Center32025
P51OD011132Emory National Primate Research Center32025
R01AI163029Inborn errors of immunity in patients with life-threatening COVID-1932025
P01CA108671Myeloproliferative Neoplasms-Research Consortium22025

1 to 10 of 1,175Source NIH's project files

See all 1,175 nih grants

Papers2,506

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Predicting chronic immune thrombocytopenia in children using IFNA17 rs9298814 polymorphism and clinical features: a study from a low- and middle-income country.Thromb Res202642600549PubTator, text miningPubMed
Plastome convergence across endoparasitic plant lineages: genome reduction, high AT bias, elevated substitution rates, and functional persistence in Mitrastemon yamamotoi.Ann Bot202642548282PubTator, text miningPubMed
Reduction of virus isolation effectiveness from throat swab double positive to H1N1pdm09 and H3N2 influenza A virus strain with SARS-CoV-2 virus in cell cultures.Mol Biol Rep202641931213PubTator, text miningPubMed
Construction of a risk prediction model for severe community-acquired pneumonia in children in Qinghai region.BMJ Paediatr Open202641922063PubTator, text miningPubMed
Sex-Specific Salivary Biochemical Composition in a Healthy Population.Int J Mol Sci202641828440PubTator, text miningPubMed
Essential role of hsa-miR-203a-3p in type I interferons immune homeostasis during influenza and NDV infection.RNA Biol202641784292PubTator, text miningPubMed
Unmasking Viral Causes of Hospitalized Respiratory Infection: Five Years of Respiratory Virus Surveillance in Vietnam by Multiplex Real-Time PCR Assay.Viruses202641754495PubTator, text miningPubMed
Changes in Serum Levels of NINJ1 and HMGB1 in Children with Kawasaki Disease and Their Clinical Significance.Biomedicines202641751301PubTator, text miningPubMed
ISG15 orchestrates dynamic crosstalk between mitochondrial fat oxidation and type 1 interferon in myeloid cells.bioRxiv202641743980PubTator, text miningPubMed
Low-dose VSV-EBOV vaccination provides rapid protection from lethal Ebola virus challenge.bioRxiv202641727071PubTator, text miningPubMed

1 to 10 of 2,506

See all 2,506 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/3451

GET https://conductscience.org/api/genes/v1/3451/patents?page=2